Crowdonomics
All companies

Black Bird Biotech, Inc.

Operating

Industrial & Manufacturing · Argyle, TX

Estimated pre-money ⓘ
$9.6M
As of Aug 2021 · from Reg A Offering (2021) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$3,212,460
Crowd $1.1M · Private $2.1M · 24 rounds since 2002
Latest share price
$0.05
Reg A+ · Equity · Aug 2021 offering price

Financials

FY2010–FY2022 · from SEC filings · hover any figure for its source
−$112K
2015
−$106K
2016
−$110K
2017
−$121K
2018
$18K
−$122K
2019
$58K
−$690K
2020
$104K
−$1.8M
2021
$83K
−$1.7M
2022
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 5 earlier years are in the table below.

Metric
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2015 audited
FY2016 audited
FY2017 audited
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
Income statement
Revenue
—
$1,116,880
—
—
—
—
—
—
—
$17,771
$57,604
$104,458
$82,563
Cost of goods sold
$653,362
$1,033,990
—
—
—
—
—
—
—
$17,802
$28,245
$84,871
$49,551
Gross margin
—
7%
—
—
—
—
—
—
—
0%
51%
19%
40%
Net income
-$8,272,310
-$160,159
-$86,515
-$89,991
-$99,519
-$112,470
-$106,268
-$110,014
-$121,110
-$121,967
-$690,158
-$1,811,302
-$1,658,766
Taxes paid
—
—
—
—
—
—
—
—
—
$0
$0
$0
$0
Balance sheet
Cash
$196,676
$49,831
$22,665
$24,184
$0
$0
$0
$0
$0
$0
$52,974
$499,766
$44,448
Accounts receivable
—
—
—
—
—
—
—
—
—
$0
$0
$2,741
$2,259
Total assets
$503,804
$49,831
$22,665
$24,184
$22,628
$12,455
$14,513
$1,573
$4,733
$973
$126,150
$774,204
$218,508
Short-term debt
—
—
—
—
—
—
—
—
—
—
$45,617
$58,333
—
Long-term debt
—
—
—
—
—
—
—
—
—
$0
$0
—
—
Total liabilities
$636,586
$342,772
$402,122
$493,631
$591,594
$693,891
$802,217
$899,291
$1,023,561
$1,141,768
$98,541
$103,994
$868,678
Other
Headcount
—
—
—
—
—
—
—
—
—
0
0
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$2.7M
est. pre-money
$1.7M
est. pre-money
$3.1M
est. pre-money
$40.5M
est. pre-money
$9.6M
est. pre-money
Private · Common · Dec 2009
Section 4(a)(2) · Common · Apr 2020
Private · Common · Sep 2020
Reg A+ · Equity · May 2020
Reg A+ · Equity · Aug 2021

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Share price over rounds

log scale
$0.75$0.05$0.0033
Jan 2007Sep 2021
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Apr 2020 (-97.3%) · Aug 2020 (-85.2%) · Sep 2020 (-50%)

“Today's shares” restates every price in the share terms current now, so a price before a split or an LLC→corporation conversion is divided by that event's ratio (each event is cited on the round page). Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Sep 30, 2023
Preferred stock · 0.01%Common stock · 100.0%
ClassOutstandingVotes / shareShare of totalLast price
Preferred stockpreferred42,000—0.01%—
Common stock310,695,330—100.0%$0.05Aug 2021
Total310,737,330100%

Shares outstanding over timein today's share terms

1.8B893M0
Mar 2008Sep 2023
Common stockPreferred stockRound openedSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Sep 16, 2021

  • Eric Newlan24,658,703 shares9.76%of company
  • Owners EF19,215,740 shares7.61%of company
  • Tri-Bridge Ventures LLC18,975,860 shares7.51%of company
  • Jack Jie Qin2,831,661 shares1.12%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Team

5 people
Eric Newlan
Director, Vice President, Secretary
Fabian G. Deneault
Director, Chairman of the Board, President
William E. Sluss
Director, Vice President-Finance, Chief Financial Officer
Jack Jie Qin
Director
L. A. Newlan, Jr.
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QNov 20, 20230001477932-23-008686
    EDGAR
  • Form 10-QAug 21, 20230001477932-23-006351
    EDGAR
  • Form 10-QMay 22, 20230001477932-23-003857
    EDGAR
  • Form 10-KMar 21, 20230001477932-23-001598
    EDGAR
  • Form 10-QNov 14, 20220001477932-22-008521
    EDGAR
  • Form 10-QAug 23, 20220001477932-22-006402
    EDGAR
  • Form 10-QMay 23, 20220001477932-22-003840
    EDGAR
  • Form 10-KApr 15, 20220001477932-22-002403
    EDGAR
Source: SEC EDGARCIK 0001409999NVShare price $0.05Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.